Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Urinary Bladder Neoplasms × Mitomycin × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Transitional Cell 2 Urinary Bladder Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Carcinoma 1

Interventions

enfortumab vedotin 3 Gemcitabine 2 Cisplatin 2 vinflunine 1 sacituzumab govitecan 1 pembrolizumab 1 durvalumab 1 avelumab 1 Paclitaxel 1 Mitomycin 1 Docetaxel 1 Carboplatin 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05243550 2024-11-04

ENVISION

UroGen Pharma Ltd.

Phase 3 Active not recruiting

240 enrolled 20 charts 1 FDA

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡